Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

22.82
Delayed Data
As of Jul 22
 -1.66 / -6.78%
Today’s Change
18.55
Today|||52-Week Range
263.81
-77.55%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues3.5B5.8B8.3B10.4B
 
 
 
 
 
Cost of Goods Sold981.2M1.8B2.1B2.4B
 
 
 
 
 
Depreciation And Amortization986.2M1.4B1.7B2.5B
 
 
 
 
 
 
Operating ExpensesGross Income1.6B2.6B4.5B5.6B
 
 
 
 
 
General Expenses835.1M1.5B2.3B3.0B
 
 
 
 
 
Other Operating Expenses0.00174.2M0.0063.1M
 
 
 
Research And Development79.1M156.8M246.0M334.4M
 
 
 
 
 
Total Operating Expenses2.8B4.8B6.0B7.9B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income744.1M979.6M2.3B2.5B
 
 
 
 
 
Extraordinary Credit5.3M--64.1M--
 
 
 
Extraordinary Charge-689.8M-1.4B-725.0M-993.8M
 
 
 
 
 
Interest Expense On Debt481.6M844.3M971.0M1.6B
 
 
 
 
 
Other Expenses21.8M-13.8M446.0M-102.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-394.2M-1.3B1.1B-155.3M
 
 
 
 
 
Income Taxes-278.2M-450.8M-180.4M-132.5M
 
 
 
 
 
Minority Interest0.00-2.5M-1.3M-3.9M
 
 
 
 
Net Income-116.0M-866.1M913.5M-291.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS305.4M321.0M335.4M342.7M
 
 
 
 
 
Shares To Calculate EPS Diluted305.4M327.5M341.5M342.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.38-$2.70$2.72-$0.85
 
 
 
 
 
EPS Diluted-$0.38-$2.70$2.67-$0.85